Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2

The global pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to efforts in developing effective vaccine approaches. Currently, approved coronavirus disease 2019 (COVID-19) vaccines are administered through an intramuscular (I.M.) route. Here, we show that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei-Chiao, Chiem, Kevin, Martinez-Sobrido, Luis, Lovell, Jonathan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505078/
https://www.ncbi.nlm.nih.gov/pubmed/36145467
http://dx.doi.org/10.3390/pathogens11091035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505078/
https://www.ncbi.nlm.nih.gov/pubmed/36145467
http://dx.doi.org/10.3390/pathogens11091035

Ejemplares similares